Resmed Inc (RMD) Stock Price, Quote & News

Company Profile

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company operates in two segments, Sleep and Breathing Health, and Residential Care Software. It offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry,...

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 858-836-5000

Website: www.resmed.co.in

Address:

9001 Spectrum Center Boulevard, San Diego, United States

Joel50jp Oct. 8 at 7:11 PM

$IXHL does anyone have a link for the $RMD call on the 24th

0 · Reply

BarfsterWoolSmittens Oct. 8 at 6:44 PM

$IXHL $RMD ResMed appears to be extremely serious about acquiring $IXHL - otherwise they would not have “convinced” Incannex to accept one of their top scientists, Dr Allison Wimms, onto their ADVISORY board to oversee the development of REPOSA.

1 · Reply

MoneyGroupLLC Oct. 8 at 6:52 AM

Enter: $RMD NOV 21 2025 $290 CALLS Buy in Price: $11.40 - $11.80 Take Profit: $24.05 Stop Bleeding: $10.03 ROI Potential: 111% Exit Within: 289 Minutes https://moneygroup.us/alerts

0 · Reply

LiquidThetaLEAPS Oct. 8 at 6:09 AM

LiquidTheta® LEAPS LIVE Actionable Alert Asset: $RMD Current Share Price: $283.47 Contracts: $RMD January 15, 2027 $290 Calls Scale in: $31.39- $38.36 Scale out: $48.82-$62.77 Can Easily Capture: 60% ROI Blended DTE: 465 Days | Join Elites here: https://liquidtheta.com/

0 · Reply

SuperGreenToday Oct. 7 at 8:28 PM

$RMD Share Price: $283.39 Contract Selected: Apr 17, 2026 $290 Calls Buy Zone: $18.36 – $22.68 Target Zone: $30.56 – $37.35 Potential Upside: 57% ROI Time to Expiration: 191 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

va4f6 Oct. 7 at 7:23 PM

$IXHL $IXHL REPOSA Advisory Board of 7 doctors include THREE Big Pharma (OSA) specialists from $NVO $RMD $JAZZ so of course the REPOSA Phase 2 results were outstanding with NO side effects!! CEO has 3 Big Pharma's helping to deliver REPOSA to the US Market! Phase 2 was a game changer!!!

0 · Reply

MoneyGroupLLC Oct. 7 at 3:20 AM

Enter: $RMD NOV 21 2025 $290 CALLS Buy in Price: $6.20 - $11.50 Take Profit: $14.76 Stop Bleeding: $5.46 ROI Potential: 138% Exit Within: 295 Minutes https://moneygroup.us/alerts

0 · Reply

LiquidThetaLEAPS Oct. 6 at 11:08 PM

LiquidTheta® LEAPS LIVE Actionable Alert Asset: $RMD Current Share Price: $280.03 Contracts: $RMD January 15, 2027 $290 Calls Scale in: $31.39- $38.36 Scale out: $48.82-$62.77 Can Easily Capture: 60% ROI Blended DTE: 466 Days | Join Elites here: https://liquidtheta.com/options

0 · Reply

va4f6 Oct. 5 at 5:57 PM

$IXHL $NVO $RMD $AXSM

0 · Reply

MoneyGroupLLC Oct. 5 at 1:21 PM

Enter: $RMD NOV 21 2025 $280 CALLS Buy in Price: $12.00 - $14.40 Take Profit: $28.68 Stop Bleeding: $10.56 ROI Potential: 139% Exit Within: 221 Minutes https://moneygroup.us/alerts

0 · Reply

Top 50 High-Quality Dividend Growth Stocks For October 2025

AAPL ACN ALLE AMAT APH CTAS DHI

Sep 23, 2025, 11:53 AM EDT - 15 days ago

ResMed Inc. (RMD) Presents at Bank of America Global Healthcare Conference 2025 Transcript

Sep 16, 2025, 4:05 PM EDT - 22 days ago

Resmed Announces Participation in the Bank of America Global Healthcare Conference 2025

Sep 8, 2025, 9:00 PM EDT - 4 weeks ago

The sleep economy is 'having a moment', says medical equipment firm Resmed

Sep 6, 2025, 12:18 PM EDT - 4 weeks ago

Top 50 High-Quality Dividend Stocks For September 2025

AAPL ACN ALLE AMAT APH CTAS DHI

Sep 3, 2025, 4:15 PM EDT - 5 weeks ago

Resmed Launches Sleep Institute to Elevate Sleep Health as a Global Priority

Aug 27, 2025, 9:00 AM EDT - 6 weeks ago

Obstructive Sleep Apnea Expected to Affect Nearly 77 million U.S. Adults by 2050, New Resmed Study Finds

Aug 27, 2025, 7:43 AM EDT - 6 weeks ago

ResMed: A Dividend Opportunity In The MedTech Space As The Company Grows

Aug 18, 2025, 4:15 PM EDT - 7 weeks ago

Resmed Announces Election of Nicole Mowad-Nassar to Board of Directors and Upcoming Retirement of Rich Sulpizio

Aug 6, 2025, 11:50 AM EDT - 2 months ago

Top 50 High-Quality Dividend Stocks For August 2025

AAPL ACN ALLE AMAT APH CTAS DHI

Aug 1, 2025, 2:16 PM EDT - 2 months ago

ResMed Analysts Increase Their Forecasts After Strong Q2 Earnings

Jul 31, 2025, 9:39 PM EDT - 2 months ago

ResMed Inc. (RMD) Q4 2025 Earnings Call Transcript

Jul 31, 2025, 4:53 PM EDT - 2 months ago

Resmed beats quarterly profit estimates on strong demand for sleep devices

Jul 31, 2025, 4:05 PM EDT - 2 months ago

Resmed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2025

Jul 30, 2025, 6:08 AM EDT - 2 months ago

Spot Outliers Like ResMed Early with Money Flows

Jul 1, 2025, 9:02 PM EDT - 3 months ago

Top 15 High-Growth Dividend Stocks For July 2025

APH BAC BK DKS DPZ ELV GPN

Jul 1, 2025, 4:05 PM EDT - 3 months ago

Resmed to Report Fourth Quarter Fiscal 2025 Earnings on July 31, 2025

Jun 9, 2025, 5:38 AM EDT - 4 months ago

ResMed: A Sleeping Giant Hiding In Plain Sight

Jun 2, 2025, 10:00 AM EDT - 4 months ago

Top 15 High-Growth Dividend Stocks For June 2025

DKS DPZ GPN INTU KLAC LRCX MPWR

May 15, 2025, 9:00 AM EDT - 5 months ago

Resmed Champions Sleep Health as The Official Sleep Partner of The Qatar Airways British & Irish Lions Tour to Australia 2025

May 2, 2025, 11:21 AM EDT - 5 months ago

Top 15 High-Growth Dividend Stocks To Consider For May 2025

AMAT APH DKS DPZ GPN INTU LRCX

May 1, 2025, 9:00 AM EDT - 5 months ago

Resmed Acquires VirtuOx

Apr 24, 2025, 3:24 PM EDT - 5 months ago

ResMed Boasts Double-Digit EPS Growth, Tariff Exemption: Analysts Boost Price Forecast

Apr 24, 2025, 5:12 AM EDT - 5 months ago

ResMed: Cornering The Market In Sleep Solutions

Apr 23, 2025, 7:16 PM EDT - 5 months ago

ResMed Inc. (RMD) Q3 2025 Earnings Call Transcript

Apr 23, 2025, 5:08 PM EDT - 6 months ago

ResMed slightly beats quarterly profit estimates on sleep devices demand

Apr 23, 2025, 4:05 PM EDT - 6 months ago

Resmed Inc. Announces Results for the Third Quarter of Fiscal Year 2025

Apr 21, 2025, 5:00 PM EDT - 6 months ago

Resmed Names Salli Schwartz as Chief Investor Relations Officer

Apr 3, 2025, 9:00 AM EDT - 6 months ago

Resmed Announces Small, Easy to Use Home Sleep Apnea Test, NightOwl™, Now Available Across the US

Apr 2, 2025, 4:05 PM EDT - 6 months ago

Resmed to Report Third Quarter Fiscal 2025 Earnings on April 23, 2025

Apr 2, 2025, 2:12 AM EDT - 6 months ago

My Top 15 High-Growth Dividend Stocks For April 2025

AMAT APH DPZ GPN INTU LRCX MPWR

Mar 19, 2025, 8:00 AM EDT - 7 months ago

New Global Study Finds: Sleep Apnea Patients Who Use CPAP Live Longer

Mar 11, 2025, 9:00 AM EDT - 7 months ago

Resmed Unveils Unified Brand to Lead the Global Sleep and Health Technology Revolution

Mar 3, 2025, 4:34 PM EST - 7 months ago

My Top 15 High-Growth Dividend Stocks For March 2025

APH DPZ GPN INTU KLAC LRCX MPWR

Feb 26, 2025, 3:00 AM EST - 8 months ago

ResMed's Fifth Annual Global Sleep Survey Reveals a World Struggling with Poor Sleep

Feb 11, 2025, 4:30 AM EST - 8 months ago

Jan De Witte joins GHO Capital as Operating Partner

IART

Feb 10, 2025, 10:38 AM EST - 8 months ago

Revisiting ResMed In 2025: Strong Q2 Financial Results And The Growing Demand For Sleep Apnea Solutions

Feb 3, 2025, 12:59 PM EST - 8 months ago

Stock Of The Day: Trading The Range In ResMed

Jan 30, 2025, 9:10 PM EST - 8 months ago

ResMed Inc. (RMD) Q2 2025 Earnings Call Transcript

Jan 30, 2025, 5:21 PM EST - 8 months ago

ResMed beats quarterly profit estimates on demand for sleep disorder devices

Jan 30, 2025, 4:05 PM EST - 8 months ago

ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2025

Jan 12, 2025, 12:52 PM EST - 9 months ago

Top 50 High Quality Dividend Growth Stocks - January 2025

MA MPWR MSCI QCOM RACE ROL ZTS

Jan 9, 2025, 4:05 PM EST - 9 months ago

ResMed to Report Second Quarter Fiscal 2025 Earnings on January 30, 2025

Jan 6, 2025, 4:05 PM EST - 9 months ago

ResMed Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference

Jan 2, 2025, 10:49 PM EST - 9 months ago

My Top 15 High Growth Dividend Stocks For January 2025

APH DPZ ELV GPN INTU MA MPWR

Dec 23, 2024, 2:59 PM EST - 10 months ago

Sleep Apnea Device Maker Stocks Slide on FDA Ruling for Eli Lilly's Zepbound

INSP LLY

Dec 4, 2024, 4:13 AM EST - 11 months ago

Canada Sleep Apnea Devices Market Research Report 2024: Opportunities and Forecasts to 2029 Featuring Braebon Medical, VitalAire, FPM Solutions, SomnoMed, and ResMed

Dec 2, 2024, 6:00 AM EST - 11 months ago

My Top 15 High-Growth Dividend Stocks For December 2024

ACN APH CNI DPZ ELV GPN INTU

Nov 5, 2024, 4:05 PM EST - 1 year ago

ResMed Announces Participation in the UBS Global Healthcare Conference

Nov 3, 2024, 2:44 PM EST - 1 year ago

My Top 15 High-Growth Dividend Stocks For November 2024

ACN APH DPZ ELV GPN INTU LRCX

Joel50jp Oct. 8 at 7:11 PM

$IXHL does anyone have a link for the $RMD call on the 24th

0 · Reply

BarfsterWoolSmittens Oct. 8 at 6:44 PM

1 · Reply

MoneyGroupLLC Oct. 8 at 6:52 AM

Enter: $RMD NOV 21 2025 $290 CALLS Buy in Price: $11.40 - $11.80 Take Profit: $24.05 Stop Bleeding: $10.03 ROI Potential: 111% Exit Within: 289 Minutes https://moneygroup.us/alerts

0 · Reply

LiquidThetaLEAPS Oct. 8 at 6:09 AM

0 · Reply

SuperGreenToday Oct. 7 at 8:28 PM

0 · Reply

va4f6 Oct. 7 at 7:23 PM

0 · Reply

MoneyGroupLLC Oct. 7 at 3:20 AM

Enter: $RMD NOV 21 2025 $290 CALLS Buy in Price: $6.20 - $11.50 Take Profit: $14.76 Stop Bleeding: $5.46 ROI Potential: 138% Exit Within: 295 Minutes https://moneygroup.us/alerts

0 · Reply

LiquidThetaLEAPS Oct. 6 at 11:08 PM

0 · Reply

va4f6 Oct. 5 at 5:57 PM

$IXHL $NVO $RMD $AXSM

0 · Reply

MoneyGroupLLC Oct. 5 at 1:21 PM

Enter: $RMD NOV 21 2025 $280 CALLS Buy in Price: $12.00 - $14.40 Take Profit: $28.68 Stop Bleeding: $10.56 ROI Potential: 139% Exit Within: 221 Minutes https://moneygroup.us/alerts

0 · Reply

TroyTH3939393 Oct. 5 at 3:04 AM

$IXHL $NVO $RMD $AXSM

0 · Reply

NOOBofNASDAQ Oct. 5 at 1:23 AM

$AXSM $IXHL $NVO $RMD

2 · Reply

MikiTrader Oct. 4 at 6:14 PM

$RMD I don't really want to believe it, but it looks like a downtrend is imminent. It feels like it's getting bigger, but the catalysts aren't keeping pace. Although RMD is in a long-term growth industry, there is also tremendous selling pressure beneath the surface.

0 · Reply

LiquidThetaLEAPS Oct. 4 at 9:25 AM

LiquidTheta® LEAPS LIVE Actionable Alert Asset: $RMD Current Share Price: $278.59 Contracts: $RMD January 15, 2027 $280 Calls Scale in: $35.96- $43.95 Scale out: $55.93-$71.91 Can Easily Capture: 60% ROI Blended DTE: 469 Days | Join Elites here: https://liquidtheta.com/options

0 · Reply

SweepCastApp Oct. 4 at 7:39 AM

$RMD: Unusual Options Activity Alerted PUT flow observed 69x contracts at Strike price of $270 Exp on 10/17/2025 with Premium of $34K and showing BULLISH Sentiment

0 · Reply

NOOBofNASDAQ Oct. 3 at 5:04 PM

$IXHL undervalued hidden gem. Look at these huge names on the Incannex team. $NVO has Robert B. Clark, Vice President of U.S. Regulatory Affairs seated on $IXHL board of directors with a multi billion dollar buyout/partnership deal. $RMD has Dr. Alison Wimms, Ph.D., from ResMed, is appointed as an advisor to the IHL-42X Obstructive Sleep Apnea (OSA) Clinical Advisory Board. $AXSM has George E. Anastassov, MD, DDS, MBA as a Non-Executive Director. He is a Co-Founder and previous CEO of AXIM Biotechnologies.

1 · Reply

Ernesto62 Oct. 3 at 4:42 PM

$IXHL $RMD yes

1 · Reply

SuperGreenToday Oct. 3 at 3:02 PM

$RMD Share Price: $279.85 Contract Selected: Apr 17, 2026 $270 Calls Buy Zone: $26.61 – $32.87 Target Zone: $46.12 – $56.37 Potential Upside: 64% ROI Time to Expiration: 195 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

MoneyGroupLLC Oct. 3 at 4:13 AM

Enter: $RMD NOV 21 2025 $280 CALLS Buy in Price: $10.98 - $11.70 Take Profit: $25.91 Stop Bleeding: $9.66 ROI Potential: 136% Exit Within: 169 Minutes https://moneygroup.us/alerts

0 · Reply

CycleTrade Oct. 2 at 10:51 PM

$RMD could be of interst

0 · Reply

MoneyGroupLLC Oct. 2 at 10:20 AM

Enter: $RMD NOV 21 2025 $280 CALLS Buy in Price: $9.60 - $10.20 Take Profit: $20.16 Stop Bleeding: $8.45 ROI Potential: 110% Exit Within: 166 Minutes https://moneygroup.us/alerts

0 · Reply

LiquidThetaLEAPS Oct. 2 at 7:13 AM

LiquidTheta® LEAPS LIVE Actionable Alert Asset: $RMD Current Share Price: $270.85 Contracts: $RMD January 15, 2027 $280 Calls Scale in: $33.71- $41.20 Scale out: $52.43-$67.41 Can Easily Capture: 60% ROI Blended DTE: 471 Days | Join Elites here: https://liquidtheta.com/options

0 · Reply

Market Cap	41.06B
Revenue (ttm)	5.15B
Net Income (ttm)	1.40B
EPS (ttm)	N/A
PE Ratio	29.17
Forward PE	25.80
Profit Margin	27.22%
Debt to Equity Ratio	0.11

Volume	888,103
Avg Vol	1,022,666
Day's Range	N/A - N/A
Shares Out	145.94M
Stochastic %K	96%
Beta	0.83
Analysts	Sell
Price Target	$290.92